Cocrystal Pharma Long Term Debt 2008-2020 | COCP

Cocrystal Pharma long term debt from 2008 to 2020. Long term debt can be defined as the sum of all long term debt fields.
Cocrystal Pharma Annual Long Term Debt
(Millions of US $)
2019 $1
2018 $0
2017 $1
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $3
2010 $3
2009 $
2008 $
2007 $
Cocrystal Pharma Quarterly Long Term Debt
(Millions of US $)
2020-03-31 $0
2019-12-31 $1
2019-09-30 $1
2019-06-30 $1
2019-03-31 $1
2018-12-31 $0
2018-09-30
2018-06-30
2018-03-31 $2
2017-12-31 $1
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30 $3
2013-06-30 $3
2013-03-31 $3
2012-12-31
2012-09-30 $3
2012-06-30 $3
2012-03-31 $3
2011-12-31 $3
2011-09-30 $3
2011-06-30 $3
2011-03-31
2010-12-31 $3
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
2008-12-31
2008-09-30
2008-06-30
2008-03-31
2007-09-30
2007-06-30
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.048B $0.007B
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs. CC-31244 is a Phase 2a ready broad-spectrum novel non-nucleoside replication inhibitor of HepC. Phase 1b studies in HepC infected patients showed the largest reduction in viral load of any non-nucleoside inhibitor tested to date. The next step for CC-31244 is clinical trials as part of a cocktail for ultra-short therapy of 2 to 6 weeks. The lead candidate for influenza has advanced to IND-enabling studies. It is effective in animal models against both the pandemic and seasonal strains of influenza. In addition, the Company has a pipeline of promising early preclinical programs. Two private investors own approximately 48% of the Company.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $132.750B 14.62
Gilead Sciences (GILD) United States $96.273B 12.48
CSL (CSLLY) Australia $91.019B 0.00
Vertex Pharmaceuticals (VRTX) United States $68.887B 47.36
Regeneron Pharmaceuticals (REGN) United States $65.681B 25.32
Illumina (ILMN) United States $52.054B 53.49
Biogen (BIIB) United States $50.053B 8.57
Seattle Genetics (SGEN) United States $25.687B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.441B 10.93
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.533B 0.00
Moderna (MRNA) United States $21.602B 0.00
Incyte (INCY) United States $20.327B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.133B 173.44
Genmab (GMAB) Denmark $18.983B 15.63
Genmab (GNMSF) Denmark $17.800B 52.85
Alnylam Pharmaceuticals (ALNY) United States $14.650B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
BeiGene (BGNE) Cayman Islands $13.305B 0.00
Exact Sciences (EXAS) United States $12.987B 0.00
Galapagos (GLPG) Belgium $12.908B 38.22
Sarepta Therapeutics (SRPT) United States $11.542B 0.00
BioNTech SE (BNTX) Germany $11.128B 0.00
ARGENX SE-ADR (ARGX) Netherlands $10.621B 0.00
QIAGEN (QGEN) Netherlands $9.982B 29.03
Bio-Techne Corp (TECH) United States $9.807B 64.79
Horizon Therapeutics Public (HZNP) Ireland $9.180B 22.59
Guardant Health (GH) United States $7.871B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.109B 0.00
Immunomedics (IMMU) United States $7.085B 0.00
Exelixis (EXEL) United States $6.860B 24.05
Ascendis Pharma (ASND) Denmark $6.765B 0.00
Repligen (RGEN) United States $6.290B 110.33
Acceleron Pharma (XLRN) United States $4.927B 0.00
Adaptive Biotechnologies (ADPT) United States $4.914B 0.00
MyoKardia (MYOK) United States $4.585B 0.00
Emergent Biosolutions (EBS) United States $4.557B 29.87
China Biologic Products (CBPO) China $4.290B 23.85
Mirati Therapeutics (MRTX) United States $4.245B 0.00
Reata Pharmaceuticals (RETA) United States $4.198B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.171B 0.00
MorphoSys AG (MOR) Germany $4.163B 32.29
Zai Lab (ZLAB) China $4.074B 0.00
Bluebird Bio (BLUE) United States $3.950B 0.00
Vir Biotechnology (VIR) United States $3.916B 0.00
Global Blood Therapeutics (GBT) United States $3.875B 0.00
Blueprint Medicines (BPMC) United States $3.857B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.799B 83.01
Momenta Pharmaceuticals (MNTA) United States $3.791B 0.00
Amicus Therapeutics (FOLD) United States $3.321B 0.00
Arena Pharmaceuticals (ARNA) United States $3.255B 0.00
Halozyme Therapeutics (HALO) United States $3.205B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.083B 0.00
NeoGenomics (NEO) United States $2.901B 211.85
Denali Therapeutics (DNLI) United States $2.739B 0.00
Alkermes (ALKS) Ireland $2.729B 53.72
Novavax (NVAX) United States $2.684B 0.00
Insmed (INSM) United States $2.610B 0.00
UniQure (QURE) Netherlands $2.609B 0.00
Amarin (AMRN) Ireland $2.575B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.567B 0.00
Viela Bio (VIE) United States $2.536B 0.00
Alector (ALEC) United States $2.370B 0.00
Fate Therapeutics (FATE) United States $2.192B 0.00
Eidos Therapeutics (EIDX) United States $1.985B 0.00
Ligand Pharmaceuticals (LGND) United States $1.958B 76.25
Principia Biopharma (PRNB) United States $1.921B 0.00
Inovio Pharmaceuticals (INO) United States $1.886B 0.00
Adverum Biotechnologies (ADVM) United States $1.820B 0.00
Epizyme (EPZM) United States $1.736B 0.00
Zymeworks (ZYME) Canada $1.667B 0.00
Sangamo Therapeutics (SGMO) United States $1.547B 0.00
Akcea Therapeutics (AKCA) United States $1.540B 0.00
PHARMA MAR SA (PHMMF) Spain $1.538B 0.00
Twist Bioscience (TWST) United States $1.536B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.498B 0.00
Mesoblast (MESO) Australia $1.491B 0.00
Editas Medicine (EDIT) United States $1.466B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.464B 0.00
Zealand Pharma (ZEAL) Denmark $1.464B 0.00
Intra-Cellular Therapies (ITCI) United States $1.435B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
NGM Biopharmaceuticals (NGM) United States $1.408B 0.00
Arvinas (ARVN) United States $1.393B 0.00
REGENXBIO (RGNX) United States $1.391B 0.00
Mersana Therapeutics (MRSN) United States $1.344B 0.00
Arcus Biosciences (RCUS) United States $1.338B 0.00
Coherus BioSciences (CHRS) United States $1.335B 9.32
Beam Therapeutics (BEAM) United States $1.325B 0.00
I-Mab (IMAB) China $1.312B 0.00
Revance Therapeutics (RVNC) United States $1.284B 0.00
Myriad Genetics (MYGN) United States $1.229B 63.38
Cytokineticsorporated (CYTK) United States $1.204B 0.00
Intellia Therapeutics (NTLA) United States $1.046B 0.00
Athenex (ATNX) United States $1.016B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.979B 0.00
Compugen (CGEN) Israel $0.931B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.908B 0.00
Pharming Group (PHGUF) Netherlands $0.889B 0.00
Sorrento Therapeutics (SRNE) United States $0.864B 0.00
Heska (HSKA) United States $0.855B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.777B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.746B 0.00
Kala Pharmaceuticals (KALA) United States $0.742B 0.00
Codexis (CDXS) United States $0.721B 0.00
Cara Therapeutics (CARA) United States $0.719B 0.00
Kadmon Holdings (KDMN) United States $0.717B 0.00
Retrophin (RTRX) United States $0.702B 0.00
NextCure (NXTC) United States $0.701B 0.00
Cue Biopharma (CUE) United States $0.695B 0.00
Cellectis S.A (CLLS) France $0.695B 0.00
Morphic Holding (MORF) United States $0.671B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.666B 0.00
Vericel (VCEL) United States $0.665B 122.83
Alcobra (ARCT) United States $0.650B 0.00
Castle Biosciences (CSTL) United States $0.649B 0.00
Agenus (AGEN) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.626B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.625B 5.36
Bellus Health (BLU) Canada $0.623B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.610B 0.00
DBV Technologies S.A (DBVT) France $0.600B 0.00
Frequency Therapeutics (FREQ) United States $0.583B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.565B 0.00
Dynavax Technologies (DVAX) United States $0.561B 0.00
UROGEN PHARMA (URGN) United States $0.561B 0.00
Intrexon (PGEN) United States $0.548B 0.00
Athersys (ATHX) United States $0.546B 0.00
NantKwest (NK) United States $0.546B 0.00
MeiraGTx Holdings (MGTX) United States $0.536B 0.00
Cel-Sci (CVM) United States $0.534B 0.00
AnaptysBio (ANAB) United States $0.530B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.528B 0.00
Anika Therapeutics (ANIK) United States $0.525B 16.88
Clovis Oncology (CLVS) United States $0.514B 0.00
Scholar Rock Holding (SRRK) United States $0.508B 0.00
BioDelivery Sciences (BDSI) United States $0.481B 25.32
Aquinox Pharmaceuticals (NLTX) United States $0.468B 0.00
VBI Vaccines (VBIV) United States $0.461B 0.00
AC Immune SA (ACIU) Switzerland $0.444B 0.00
Protagonist Therapeutics (PTGX) United States $0.440B 0.00
Merus (MRUS) Netherlands $0.433B 0.00
Prothena (PRTA) Ireland $0.429B 0.00
Puma Biotechnology (PBYI) United States $0.418B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.414B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.412B 0.00
Syros Pharmaceuticals (SYRS) United States $0.402B 0.00
Albireo Pharma (ALBO) United States $0.399B 0.00
ANI Pharmaceuticals (ANIP) United States $0.389B 7.71
PDL BioPharma (PDLI) United States $0.388B 333.00
MiMedx (MDXG) United States $0.387B 0.00
CytomX Therapeutics (CTMX) United States $0.370B 0.00
Precision BioSciences (DTIL) United States $0.370B 0.00
Avid Bioservices (CDMO) United States $0.364B 0.00
Kamada (KMDA) Israel $0.355B 14.78
OSMOTICA PHARM (OSMT) United States $0.354B 0.00
Seres Therapeutics (MCRB) United States $0.340B 0.00
WAVE Life Sciences (WVE) Singapore $0.322B 0.00
Selecta Biosciences (SELB) United States $0.318B 0.00
Geron (GERN) United States $0.313B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.308B 0.00
Verastem (VSTM) United States $0.306B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.305B 0.00
MannKind (MNKD) United States $0.298B 0.00
ChromaDex (CDXC) United States $0.282B 0.00
Menlo Therapeutics (MNLO) United States $0.281B 0.00
Pfenex (PFNX) United States $0.278B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.277B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Affimed (AFMD) Germany $0.265B 0.00
Exicure (XCUR) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.257B 0.00
Spero Therapeutics (SPRO) United States $0.256B 0.00
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Northwest Biotherapeutics (NWBO) United States $0.252B 0.00
Gritstone Oncology (GRTS) United States $0.251B 0.00
Cellular Biomedicine (CBMG) United States $0.246B 0.00
Fortress Biotech (FBIO) United States $0.245B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
XOMA (XOMA) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.228B 0.00
Prometic Life Sciences (LMNL) Canada $0.222B 0.00
POXEL SA FRANCE (PXXLF) France $0.217B 0.00
Liquidia Technologies (LQDA) United States $0.214B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.212B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.209B 3.15
IVERIC Bio (ISEE) United States $0.205B 0.00
GENFIT S.A (GNFT) France $0.204B 0.00
ARAVIVE, INC (ARAV) United States $0.194B 0.00
VTv Therapeutics (VTVT) United States $0.192B 0.00
Pluristem Therapeutics (PSTI) Israel $0.192B 0.00
Strongbridge Biopharma (SBBP) United States $0.191B 0.00
TELA Bio (TELA) United States $0.188B 0.00
Kindred Biosciences (KIN) United States $0.185B 0.00
Aduro Biotech (ADRO) United States $0.184B 0.00
IBio (IBIO) United States $0.183B 0.00
Five Prime Therapeutics (FPRX) United States $0.180B 0.00
Aytu Bioscience (AYTU) United States $0.178B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.175B 0.00
Orgenesis (ORGS) United States $0.169B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Celyad SA (CYAD) Belgium $0.166B 0.00
Cerecor (CERC) United States $0.163B 0.00
Aptinyx (APTX) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.153B 0.00
Cyclerion Therapeutics (CYCN) United States $0.150B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
PHASEBIO PHARMA (PHAS) United States $0.146B 0.00
Cidara Therapeutics (CDTX) United States $0.144B 0.00
Arbutus Biopharma (ABUS) Canada $0.141B 0.00
Trevena (TRVN) United States $0.140B 0.00
Theratechnologies (THTX) Canada $0.135B 0.00
Applied Genetic Technologies (AGTC) United States $0.134B 0.00
Palatin Technologies (PTN) United States $0.134B 3.44
Lineage Cell Therapeutics (LCTX) United States $0.133B 0.00
VolitionRX (VNRX) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.118B 0.00
Protalix BioTherapeutics (PLX) Israel $0.116B 0.00
Antibe Therapeutics (ATBPF) Canada $0.114B 0.00
Lumos Pharma (LUMO) United States $0.114B 0.00
Eton Pharmaceuticals (ETON) United States $0.113B 0.00
Checkpoint Therapeutics (CKPT) United States $0.113B 0.00
AIT Therapeutics (XAIR) United States $0.112B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Oncobiologics (OTLK) United States $0.109B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.102B 0.00
Windtree Therapeutics (WINT) United States $0.098B 0.00
Clearside Biomedical (CLSD) United States $0.096B 0.00
Catalyst Biosciences (CBIO) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.087B 0.00
SESEN BIO, INC (SESN) United States $0.087B 0.00
AquaBounty Technologies (AQB) United States $0.084B 0.00
AnPac Bio-Medical Science (ANPC) China $0.083B 0.00
Celsion (CLSN) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.078B 0.00
Synlogic (SYBX) United States $0.078B 0.00
Stealth BioTherapeutics (MITO) United States $0.072B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.067B 0.00
Idera Pharmaceuticals (IDRA) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.061B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.060B 0.00
CollPlant Holdings (CLGN) Israel $0.059B 0.00
Celldex Therapeutics (CLDX) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.057B 0.00
Ecology Coatings (ABVC) United States $0.057B 0.00
Soligenix (SNGX) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Apricus Biosciences (SEEL) United States $0.051B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.047B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Signal Genetics (MGEN) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
OvaScience (MLND) United States $0.042B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Chanticleer Holdings (SONN) United States $0.042B 0.00
TrovaGene (CRDF) United States $0.039B 0.00
Cesca Therapeutics (THMO) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Titan Pharmaceuticals (TTNP) United States $0.033B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Curis (CRIS) United States $0.030B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Spherix (AIKI) United States $0.025B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Entera Bio (ENTX) Israel $0.023B 0.00
Novogen (KZIA) Australia $0.021B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00